GSK Pharma
GSK Pharma
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100 | Ovarian Clear Cell Carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-06-23 | NCT06065462 |